The Canadian Press on MSN18h
FDA approves new painkiller that shows promise and challenges of opioid alternatives
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Charlotte’s Web Founder Aims For FDA Approval Of Autism Spectrum Disorder Drug
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
FCCE entertainment on MSN13d
Katy Perry, pop icon and trailblazer
Explore the vibrant journey of Katy Perry, a pop icon known for her electrifying music, eye-catching performances, and ...
Marianne Faithfull, singer and pop icon, dies at 78
The British pop star, muse, libertine and old soul who inspired and helped write some of the Rolling Stones’ greatest songs ...
istockphoto27d
Quality Control Approved stock illustrations
V1 Approved rubber stamp seal icon with thumbs up hand sign. Blue flag with for quality check badge design vector illustration. Recommended product with best choice logo for promotion. Like symbol. V1 ...
Quantum Biopharma Ltd. Approved to Dual List on Upstream
Detailed price information for Quantum Biopharma Ltd (QNTM-Q) from The Globe and Mail including charting and trades.
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
FDA Approves Painkiller Designed to Eliminate the Risk of Addiction Associated With Opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
FDA Approves Vertex Pharma's JOURNAVX As The First Drug In A New Class Of Non-Opioid Pain Medicines
Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...